SAI SREYAS PHARMACEUTICAL PRIVATE LIMITED

SAI SREYAS PHARMACEUTICAL PRIVATE LIMITED (India) holds 12 active US FDA Type II Drug Master Files. No FDA recall, Warning Letter or Form 483 record is linked to it, which is not proof that none exists.

Sources: FDA Drug Master File list, EDQM certification database, FDA establishment registrations and enforcement records. How we read these records

Cite as: PharmaTek, “SAI SREYAS PHARMACEUTICAL PRIVATE LIMITED: DMF, site and FDA enforcement record”, record as of 16 Nov 2026, pharmatek.co.uk/directory/sai-sreyas-pharmaceutical-private-limited

Overview

SAI SREYAS PHARMACEUTICAL PRIVATE LIMITED is an active pharmaceutical ingredient (API) supplier with 8 active FDA Type II Drug Master Files, covering ALECTINIB INTERMEDIATE- TERT-BUTYL 6-CYANO-2-(2-(4-ETHYL-3-IODOPHENYL) PROPAN-2-YL)-1H-INDOLE-3-CARBOXYLATE (TBC) IH (CAS NUMBER- 1256584-75-4); OLANZAPINE INTERMEDIATE- 4-AMINO-2-METHYL-10H-THIENE[2,3-B][1,5]BENZODIAZEPINE HYDROCHLORIDE (OLZ-3) IH (CAS NUMBER- 138564-60-0); RESMETIROM INTERMEDIATE – 3,6-DICHLORO-4-ISOPROPYLPYRIDAZINE (DIP IH) (CAS NO. 107228-51-3); RESMETIROM INTERMEDIATE- N-CYANOACETYL URETHANE (NCA) (CAS 6629-04-5)”.; RIVAROXABAN INTERMEDIATE – 4-{4-[(5S)-5-(AMINOMETHYL)-2-OXO-1,3-OXAZOLIDIN-3-YL]PHENYL}MORPHOLIN-3-ONE HYDROCHLORIDE (RVB-3); RIVAROXABAN INTERMEDIATE (2-{[(2S)OXIRAN-2-YL]METHYL}-1H-ISOINDOLE-1,3(2H)-DIONE (RIVB)), CAS NO. [161596-47-0].

API / Drug Master Files

SAI SREYAS PHARMACEUTICAL PRIVATE LIMITED holds 12 active (12 total) FDA Type II Drug Master Files. A Type II DMF is filed with the FDA to support an active ingredient in drug applications; an active filing can be referenced but is not proof of current supply, and inactive filings are historical.

  • RESMETIROM INTERMEDIATE- 6-(4-AMINO-2,6-DICHLOROPHENOXY)-4-ISOPROPYLPYRIDAZIN-3(2H)-ONE (CAS NO.-920509-28-0)Active2026-07-21
  • ETORICOXIB INTERMEDIATE- 1-(6-METHYLPYRIDIN-3-YL)-2-(4-(METHYLSULFONYL)PHENYL)ETHANONE (ETC-4) (CAS NO.-221615-75-4)Active2026-07-15
  • RESMETIROM INTERMEDIATE- 3,5-DICHLORO-4-((6-CHLORO-5-ISOPROPYLPYRIDAZIN-3-YL)OXY)ANILINE (ECC-1) (CAS NO.-920509-27-9)Active2026-07-11
  • OLANZAPINE INTERMEDIATE- 4-AMINO-2-METHYL-10H-THIENE[2,3-B][1,5]BENZODIAZEPINE HYDROCHLORIDE (OLZ-3) IH (CAS NUMBER- 138564-60-0)Active2026-01-24
  • EMPAGLIFLOZIN INTERMEDIATE- (2R,3R,4R,5S,6S)-2-(ACETOXYMETHYL)-6-(4-CHLORO-3-(4-(((S)-TETRAHYDROFURAN-3-YL)OXY)BENZYL)PHENYL)TETRAHYDRO-2H-PYRAN-3,4,5-TRIYL TRIACETATE (EMP-5) (CAS NO.- 915095-99-7)Active2026-01-24
  • RIVAROXABAN INTERMEDIATE- (5-CHLOROTHIOPHENE-2-CARBOXYLIC ACID (RIV-C)), (CAS NO. 24065-33-6)Active2025-11-28
  • RIVAROXABAN INTERMEDIATE (2-{[(2S)OXIRAN-2-YL]METHYL}-1H-ISOINDOLE-1,3(2H)-DIONE (RIVB)), CAS NO. [161596-47-0]Active2025-10-30
  • RESMETIROM INTERMEDIATE – 3,6-DICHLORO-4-ISOPROPYLPYRIDAZINE (DIP IH) (CAS NO. 107228-51-3)Active2025-09-18
  • RIVAROXABAN INTERMEDIATE – 4-{4-[(5S)-5-(AMINOMETHYL)-2-OXO-1,3-OXAZOLIDIN-3-YL]PHENYL}MORPHOLIN-3-ONE HYDROCHLORIDE (RVB-3)Active2025-08-25
  • ALECTINIB INTERMEDIATE- TERT-BUTYL 6-CYANO-2-(2-(4-ETHYL-3-IODOPHENYL) PROPAN-2-YL)-1H-INDOLE-3-CARBOXYLATE (TBC) IH (CAS NUMBER- 1256584-75-4)Active2025-08-06
  • RESMETIROM INTERMEDIATE- N-CYANOACETYL URETHANE (NCA) (CAS 6629-04-5)”.Active2025-07-09
  • SITAGLIPTIN INTERMEDIATE [3-(TRIFLUOROMETHYL)-5H,6H,7H,8H-[1,2,4] TRIAZOLO[4,3-A] PYRAZINE HYDROCHLORIDE)]Active2023-12-11

FDA compliance signals

No FDA recalls, Warning Letters, or Form 483 observations are linked to SAI SREYAS PHARMACEUTICAL PRIVATE LIMITED in our records. Events are linked by company name and identifier, so this is not proof that none exist; check the FDA's own databases before relying on it.

For suppliers

Is this SAI SREYAS PHARMACEUTICAL PRIVATE LIMITED?

Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.

Free. Payment never buys an evidence status.

Need suppliers found and checked?

The Sourcing Desk turns these records into a checked shortlist: current filings, site, grade and regulatory history confirmed for your product, for a buyer-paid fixed fee and no supplier commission.